Freeport-McMoRan Reports Q3 Copper Output, Advances Grasberg Recovery

Freeport-McMoRan produced about 830 million pounds of copper and 230,000 ounces of gold in Q3 2026, broadly in line with expectations, while delayed gold sales deferred about 60,000 ounces to Q4. Copper sales are expected at 750 million pounds and gold sales at around 100,000 ounces; unit net cash costs are projected about 5% above the July estimate of $2 per pound, while realized copper prices are expected to exceed $6.50 per pound. Grasberg operated at 67% of normalized throughput, with FCX targeting 80% capacity by mid-2027 and near-full capacity by year-end 2027; shares are up 78.7% over the past year.

Analysis

The key distinction is operational recovery versus reported sales: deferred gold sales shift earnings between quarters, while weaker by-product credits raise near-term unit costs. Treat the gold shortfall as timing unless the Oct. 27 filing shows a production or recovery issue; the cost variance matters more if it persists after gold sales normalize.

Over 1–3 months, the setup is asymmetric around execution. A high realized copper price supports cash generation, but the share’s substantial outperformance leaves less room for schedule slippage or weather-related interruptions. The market may be underweight the risk that Grasberg’s recovery is uneven: milling constraints and material-handling upgrades are separate dependencies, so throughput progress alone does not guarantee the mid-2027 capacity target. Conversely, successful ramp-up could add supply and weigh at the margin on copper pricing, benefiting metal-consuming industries while reducing scarcity value for competing producers.

For 6–18 months, Bagdad, leach initiatives and El Abra are options, not current earnings offsets; do not capitalize them as certain growth before investment decisions and regulatory clarity. The article provides no valuation, production-cost bridge, or independently verified project economics, so it does not support a price target. Main falsifiers: a revised Grasberg timetable, continued unit-cost pressure after deferred sales move into Q4, or a sustained copper-price retreat. The unrelated stock rankings and promotional content offer no relevant signal for FCX.

Key Decisions for Investors

• Avoid chasing FCX ahead of Oct. 27 earnings after its strong relative run. Hold core exposure only if the portfolio can tolerate execution volatility; consider trimming tactical overweight rather than making a fresh outright short.
• Use the earnings release as a confirmation point: add on weakness only if management maintains the Grasberg recovery schedule and costs improve as gold sales normalize. Reassess or reduce if the schedule slips or cost pressure persists.
• Monitor Grasberg throughput alongside material-handling completion and the Production Block 1S restart; throughput progress without those milestones is not sufficient confirmation of the 2027 capacity path.
• Treat Bagdad and El Abra as longer-dated upside options, not near-term catalysts, until the Bagdad investment decision and El Abra regulatory progress are clearer.